Conference Information
Dear distinguished colleagues, researchers, and healthcare leaders,Welcome to the Indonesia Clinical Genomics and Precision Medicine Forum 2026, jointly organized by BGI Group, MGI Tech, and NGI. This forum brings together experts from Indonesia and China to exchange knowledge and strengthen collaboration in clinical genomics and precision medicine at:
Date: 26 September 2026
Time: 08.30 - 17.00
Venue: The Westin Jakarta, Indonesia
As Indonesia continues to advance its digital health transformation, omics technologies are playing an increasingly important role in how diseases are understood and managed in more personalized ways. This forum reflects our shared commitment to advancing precision medicine by fostering scientific collaboration, encouraging technological innovation, and strengthening strategic partnerships across the region.
Through scientific presentations, technology showcases, and interdisciplinary discussions, participants will explore the latest developments in clinical genomics and discover how integrated genomic solutions can support the future of healthcare.
We look forward to welcoming you to Jakarta and to collaborating in advancing precision medicine for the benefit of our international community.
Speakers
Mr. Jeremy, Cao
Vice President of BGI Group
Indri Rooslamiati, M.Sc.,Apt
Director of Center for Biomedical and Health Genomics and INA-CRC
Ms. Indri Rooslamiati is a senior health policy and biomedical genomics leader at the Ministry of Health of the Republic of Indonesia, serving as Director of the Center for Biomedical and Health Genomics and the Indonesia Clinical Research Center (INA-CRC). She has held several strategic roles within the Ministry, including Head of the Healthcare Unit and Team Leader of the Biomedical Genome Science Initiative (BGSi), and is also involved in the national working group on the utilization of artificial intelligence in healthcare. She is currently pursuing her PhD at University Medical Center Utrecht, Utrecht University, the Netherlands, with experience spanning health technology, biomedical genomics, clinical research, and medical diagnostics. Her expertise and leadership contribute to Indonesia's efforts to advance genomic medicine, health technology innovation, and clinical research, including strengthening the country's clinical trial ecosystem.
Prof. Dr. Dr. M. Alamsyah Aziz, Sp.OG, Subsp.KFM, M.Kes, FISOG
Chairman of the Indonesian Fetal Maternal Medicine Association (HKFM)
Dr. M. Alamsyah Aziz is an Obstetrics and Gynecology Specialist with subspecialty expertise in Maternal-Fetal Medicine, focusing on the management of high-risk pregnancies and complex maternal and fetal conditions. A graduate of the Faculty of Medicine, Universitas Padjadjaran, he has developed expertise in invasive prenatal diagnosis, minimally invasive surgery, fetal therapy, and maternal intensive care. As a Maternal-Fetal Medicine specialist, he is dedicated to providing comprehensive care and ensuring the optimal health and well-being of both mother and fetus throughout high-risk pregnancies.
Dr. dr. R. Dina Garniasih, Sp. A., Subsp. H. O. (K)
Pediatric Hemato-Oncologist - RSAB Harapan Kita
Dr. Dina Garniasih is a Pediatric Hematology-Oncology Consultant at RSAB Harapan Kita with extensive expertise in childhood cancers, thalassemia, hemophilia, and other hematologic disorders. Combining clinical practice, research, and academic leadership, she is dedicated to delivering evidence-based, patient-centered care for children with complex medical conditions. Her work focuses on improving early diagnosis, comprehensive treatment, and long-term outcomes through advances in pediatric hematology and precision medicine.
dr. Ludi Dhyani Rahmartani, Sp. A., Subsp. H. O. (K)
Pediatric Hemato-Oncologist - RSUPN Dr, Ciptomangunkusumo
Dr. Ludi Dhyani Rahmartani is a Pediatric Hematology-Oncology Consultant with expertise in pediatric cancers and thalassemia. Having completed advanced clinical training in Thailand, Singapore, the United Kingdom, and the United States, she brings extensive international experience to patient care and research. She is actively involved in advancing pediatric hematology-oncology and genomic medicine to improve outcomes for children with complex diseases
Dr. dr. Achmad Rafli, Sp.A, Subsp. Neuro(K), FICNA
Pediatric Neurologist - RSUPN Dr. Ciptomangunkusumo
Dr. Achmad Rafli is a Pediatric Neurology Consultant specializing in neurological disorders affecting children, including neurodevelopmental disorders, epilepsy, central nervous system infections, demyelinating diseases, brain and spinal cord tumors, cerebral palsy, and seizures in infants and children. He holds qualifications in General Medicine, Pediatrics, Pediatric Neurology, and a Doctoral degree from the Faculty of Medicine, Universitas Indonesia. In addition to his clinical practice, Dr. Rafli is actively involved in research, clinical services, and community engagement in pediatric neurology. His work is dedicated to improving the quality of life and care outcomes for children living with neurological disorders.
Fang Chao, PhD
BGI Research Principal Scientist
Dr. Fang Chao is an Associate Researcher at BGI Research and Scientific Lead for the BGI PMSEQ Clinical AI Applications program, with 13 years of experience in genomics, bioinformatics, sequencing technologies, and microbiome research. His work focuses on clinical data governance, pathogen genomic modeling, and AI-enabled clinical decision support. He has led research in long-fragment microbial sequencing, cancer immunotherapy biomarkers, and metagenomic sequencing quality assessment, with publications in Cell Reports Methods, Frontiers in Oncology, and GigaScience. He holds a PhD in Molecular Biology from the University of Copenhagen.
Li Yan, PhD
BGI Research
Dr. Li Yan is a Principal Investigator specializing in aging, complex disease genomics, multi-omics research, and AI-driven biomarker discovery. His research focuses on the genetic and molecular mechanisms underlying longevity and biological aging, with publications in high-impact journals including Nature Genetics, Molecular Biology and Evolution, and Cell. He has also served as a Site Principal Investigator for international collaborative research programs involving China, Singapore, and Saudi Arabia. Dr. Yan holds a PhD in Human Genomics and Multi-omics Data Science from The University of Hong Kong and has conducted research as a visiting scholar at Harvard University and the Broad Institute.
Lagniton Philip Naderev Panuringan, PhD
BGI Health & Wellness AI engineer
Dr. Philip Naderev P. Lagniton is an AI Algorithm Engineer at BGI Genomics, specializing in computational bioinformatics and AI applications in biomedical research especiallly 133111i - Smart Health. He holds a PhD in Biomedical Sciences with a specialization in Computational Bioinformatics from the University of Macau, where his research focused on genetic variant interpretation and computational approaches to human disease. His research has contributed to studies of BRCA and TP53 variants, variant pathogenicity, and human genetic diversity, with publications in Briefings in Bioinformatics, BMC Genomics, and other peer-reviewed journals. He is also experienced in developing and deploying AI models for biological data analysis.
Liu Yangruiyu
Senior Director of SIROmics Center, BGI Precision Medicine Center
Wang Yanhong, PhD
BGI Technology
Dr. Wang Yanhong is Director of the R&D Support Department at BGI Tech Solutions (Shenzhen), specializing in genomics, single-cell, and spatial omics. She holds a PhD in Biomedicine from the University of Melbourne and graduated with honors from Nanjing University. With more than 15 years of experience in the field, she has led product development, technical support, and strategic planning, translating advanced multi-omics technologies into research applications that support precision medicine. Her work bridges scientific innovation and practical implementation across cancer biology, disease mechanisms, and population cohort studies.
Faris Muhammad Gazali, M.Sc.
Field Application Scientist, MGI Tech
Faris Muhammad Gazali is a Field Application Scientist at MGI Tech, specializing in NGS applications, sequencing platforms, automation, troubleshooting, and customer training. With over four years of experience in NGS, molecular biology, sequencing, and bioinformatics, he provides technical support and workflow optimization for customers across multiple MGI sequencing platforms, including E25, G50, G99, G400, and T7, as well as SP-100 and SP-960 automation systems. He also contributes to the Indonesian National Genome Project through technical consultation and workflow support. Faris holds an M.Sc. in Biotechnology from Universitas Gadjah Mada.
Meeting Date & Place
Date: 26 September 2026
Time: 08.30 - 17.00
Place: The Westin Jakarta, Indonesia
Onsite Meeting: Virtual link participate online will also be provided
Meeting Agenda: Please Download here
Sponsor Info
